Autologous umbilical cord blood for red cell concentrate transfusion in preterm infants in the era of delayed cord clamping: An uncontrolled clinical trial.

Thangaraj AbiramalathaKrishnamoorthy RadhakrishnanVinod Kumar PanickerBinu NinanUsharani GodlaAshok ChandrasekaranUmamaheswari BalakrishnanPrakash Amboiram

Published in: Transfusion medicine (Oxford, England) (2020)

The success rate of UCB collection after DCC for 1 minute is low. Autologous UCB meets less than one-fifth of transfusion requirements. Hence, autologous UCB transfusion is not a workable option in preterm infants.

Keyphrases

preterm infants
cell therapy
umbilical cord
mesenchymal stem cells
cardiac surgery
bone marrow
low birth weight
clinical trial
sickle cell disease
platelet rich plasma
acute kidney injury
stem cells
single cell
randomized controlled trial
phase ii
preterm birth